ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Jan 2026
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
February 2026
Nuclear Technology
January 2026
Fusion Science and Technology
November 2025
Latest News
Canada’s General Fusion to become publicly traded company
General Fusion has entered into a definitive business combination agreement with Spring Valley Acquisition Corp. (SVAC) that would make General Fusion the first publicly traded pure-play fusion firm, the company announced on January 22. The business combination is projected to be completed in mid-2026.
L. Lebaron-Jacobs, R. Fottorino, F. Barbry, P. Berard, F. Briot, P. Boisson, D. Cavadore, C. Challeton-de Vathaire, S. Distinguin, L. Exmelin, A. Flury-Herard, E. Gaillard-Lecanu, M. Gonin, J.-P. Le Goff, G. Lecoix, G. Lemaire, R. Medioni, M. H. Persico, Y. Racine, C. Riasse, E. Rongier, P. Voisin, A. Miele
Nuclear Technology | Volume 161 | Number 1 | January 2008 | Pages 27-34
Technical Paper | Reactor Safety | doi.org/10.13182/NT08-A3910
Articles are hosted by Taylor and Francis Online.
A working group from health occupational and clinical biochemistry services on French sites has issued essential data sheets on the guidelines to follow in managing the victims of a criticality accident. Since the priority of the medical management after a criticality accident is to assess the dose and the distribution of dose, some dosimetric investigations have been selected in order to provide a prompt response and to anticipate the final dose reconstruction. Comparison exercises between clinical biochemistry laboratories on French sites were carried out to confirm that each laboratory maintained the required operational methods for hair treatment and the appropriate equipment for 32P activity in hair and 24Na activity in blood measurements, and to demonstrate its ability to rapidly provide neutron dose estimates after a criticality accident. As a result, a relation has been assessed to estimate the dose and the distribution of dose according to the neutron spectrum following a criticality accident.